Definitive Contract W911SR20C0047

Award Date 8/3/20
Potential Completion Date 1/31/22
Potential Value $25M
Contracting Federal Agency
ACC Aberdeen Proving Ground
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Camarillo, CA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
16
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This definitive contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Medline Industries, LP provides for the delivery of safety syringes and needles in support of COVID-19 response efforts. The $8.2 million firm-fixed price contract calls for Medline to supply up to 500 million FDA-approved combination needle and syringe units from its Winnetka, Illinois facility between August 2020 and August 2021. This award fulfills...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Duopross Meditech Corporation a $47.7 million firm fixed price contract to supply safety syringes and needles in support of the COVID-19 response. Under the contract, Duopross Meditech will provide up to 500 million FDA-approved combination needle and syringe units from its Farmingdale, New York facility by October 2021. The syringes will include approximately 270 million 1ml syringes with 23g...
This definitive contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to HTL Strefa Inc., doing business as HTL Strefa SA, for $31,097,312.77. The prime contractor will supply safety syringes and needles to support the COVID-19 response effort. Performance will take place in Marietta, Georgia from August 3, 2020 through December 31, 2021. The original solicitation sought proposals for up to five hundred million FDA-approved...
Quality Impact Inc. was awarded a definitive contract valued at $9,579,101.94 by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to supply safety syringes and needles in support of the COVID-19 response. The firm fixed price contract runs from August 3, 2020 to August 30, 2021 and requires performance in Foster City, California. The solicitation sought up to 500 million FDA-approved combination needle and syringe units or individual sterile needles...
This federal contract was awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to the prime contractor Becton, Dickinson & Co (BD) for the procurement of needles and syringes in support of a COVID-19 mass vaccination campaign. The $20,151,725.09 firm fixed-price delivery order contract has an ultimate completion date of September 27, 2023. No set-aside designation was used. BD is a manufacturer and supplier of medical devices, instruments,...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Becton, Dickinson and Company a $19.2 million firm fixed price delivery order to procure needles and syringes in support of COVID-19 mass vaccination efforts. Performance will take place in Washington, D.C. through September 2023. This order was issued under an existing HHS contract vehicle to supply materials necessary for efficiently administering coronavirus vaccines on a...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $93.8 million firm fixed price delivery order contract to Retractable Technologies Inc. to procure needles and syringes in support of the agency's COVID-19 mass vaccination campaign. Performance will take place in Washington, D.C. over a three-year period concluding in September 2023. As the prime contractor, Retractable Technologies Inc. will deliver the requested medical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a for-profit pharmaceutical distribution company, to supply 0.3mL syringes of the COMIRNATY COVID-19 vaccine for individuals aged 12 and up. The contract has a ceiling value of $1,126.71 and a performance period through March 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $110,025.00 firm-fixed-price delivery order is for the supply of COMIRNATY (COVID-19 vaccine) syringes for individuals 12 years and older, with a completion date of September 26, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of 0.3 milliliter COMIRNATY (COVID-19) vaccine syringes for individuals 12 years and older. The $90,038.00 firm fixed-price delivery order contract has an ultimate completion date of September 5, 2024 and does not have a small business set-aside designation. This award is associated with a larger...

This $25.4 million firm-fixed-price contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Gold Coast Medical Supply LP. The contract calls for the delivery of safety syringes and needles to support the Department of Health and Human Services' COVID-19 response efforts. Specifically, the contractor will supply up to 500 million FDA-approved combination needle and syringe units in accordance with the original solicitation, which sought proposals for 270 million 1ml syringes with 23g and 25g needles and 230 million 3ml syringes with 23g and 25g needles to be delivered to seven designated cities in the U.S. by January 31, 2022. No subcontractors or set-aside designations were identified. The funding supports the Departments' medical countermeasures initiatives to equip the Strategic National Stockpile in preparation for COVID-19 vaccine distribution.

Generated 12/29/23, 3:24 PM